Antalgic therapies for painful vertebral bone metastases: a systematic review and meta-analysis, and the case for function-focused rehabilitation trials

Painful vertebral metastases are common and disabling, and several antalgic strategies are used (radiotherapy, interventional procedures, drugs and physical rehabilitation) yet their comparative efficacy, and their effect on physical function, has not been synthesised in one appraisal restricted to vertebral disease. We aimed to provide such a synthesis. We conducted a systematic review and meta-analysis of randomised controlled trials of any antalgic therapy in adults with strictly vertebral bone metastases. Four databases were searched to 20 July 2026. Risk of bias was assessed with RoB 2 and certainty with GRADE; quantitative meta-analysis (dichotomous pain response, random-effects risk ratios) was limited to the stereotactic-versus-conventional radiotherapy comparison; all other antalgic comparisons were synthesised narratively. Nineteen trials were included. Stereotactic radiotherapy more than doubled complete pain response at 3 months versus conventional radiotherapy (RR 2.26, 95% CI 1.48–3.44; I²=0%; moderate certainty); its effect on overall response was inconsistent and very uncertain (directionally opposed trials, I²=91%, not pooled), no clear evidence of an increase in vertebral compression fracture was detected (RR 0.84, 0.56–1.26; low certainty), and the 6-month complete-response estimate remained uncertain. Evidence for augmentation, ablation and pharmacological adjuncts was sparse and of low or very-low certainty. Across all 19 trials, efficacy was judged by pain; a dedicated measure of physical function or disability was reported in only three, and was primary in none. Stereotactic radiotherapy deepens the complete pain response at 3 months, whereas a broader benefit was not demonstrated and its durability at 6 months remained uncertain; no clear evidence of increased fracture risk was detected; other antalgic strategies remain weakly evidenced. Within the antalgic trials reviewed, a dedicated measure of physical function was rarely used and never a primary outcome, so function-focused rehabilitation trials are an important research priority.

Authors

Institutions

Publication Details

Journal
BMC Musculoskeletal Disorders
Published
2026-11-18
DOI
https://doi.org/10.1186/s12891-026-10739-7
Primary Topic
Management of metastatic bone disease
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Antalgic therapies for painful vertebral bone metastases: a systematic review and meta-analysis, and the case for function-focused rehabilitation trials

Carolina Fernández‐Lao, María Virginia Fernández-González, Noelia Galiano‐Castillo, Mario Lozano‐Lozano et al.
2 links
BMC Musculoskeletal Disorders
Management of metastatic bone disease
article

Antalgic therapies for painful vertebral bone metastases: a systematic review and meta-analysis, and the case for function-focused rehabilitation trials

Carolina Fernández‐Lao, María Virginia Fernández-González, Noelia Galiano‐Castillo, Mario Lozano‐Lozano, Eduardo Castro‐Martín, Antonio Jose Martín-Pérez, Gabriel Morais Xavier dos Santos
article en

Abstract

Painful vertebral metastases are common and disabling, and several antalgic strategies are used (radiotherapy, interventional procedures, drugs and physical rehabilitation) yet their comparative efficacy, and their effect on physical function, has not been synthesised in one appraisal restricted to vertebral disease. We aimed to provide such a synthesis. We conducted a systematic review and meta-analysis of randomised controlled trials of any antalgic therapy in adults with strictly vertebral bone metastases. Four databases were searched to 20 July 2026. Risk of bias was assessed with RoB 2 and certainty with GRADE; quantitative meta-analysis (dichotomous pain response, random-effects risk ratios) was limited to the stereotactic-versus-conventional radiotherapy comparison; all other antalgic comparisons were synthesised narratively. Nineteen trials were included. Stereotactic radiotherapy more than doubled complete pain response at 3 months versus conventional radiotherapy (RR 2.26, 95% CI 1.48–3.44; I²=0%; moderate certainty); its effect on overall response was inconsistent and very uncertain (directionally opposed trials, I²=91%, not pooled), no clear evidence of an increase in vertebral compression fracture was detected (RR 0.84, 0.56–1.26; low certainty), and the 6-month complete-response estimate remained uncertain. Evidence for augmentation, ablation and pharmacological adjuncts was sparse and of low or very-low certainty. Across all 19 trials, efficacy was judged by pain; a dedicated measure of physical function or disability was reported in only three, and was primary in none. Stereotactic radiotherapy deepens the complete pain response at 3 months, whereas a broader benefit was not demonstrated and its durability at 6 months remained uncertain; no clear evidence of increased fracture risk was detected; other antalgic strategies remain weakly evidenced. Within the antalgic trials reviewed, a dedicated measure of physical function was rarely used and never a primary outcome, so function-focused rehabilitation trials are an important research priority.

BMC Musculoskeletal Disorders
Universidad de Granada (ES), Universidade de São Paulo (BR), Instituto de Investigación Biosanitaria de Granada (ES), Complejo Hospitalario Universitario de Granada (ES)
Instituto de Salud Carlos III
Good health and well-being
Management of metastatic bone disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon